Medline (MDLN) Preferred Stock Liabilities (2024)

Medline's (MDLN) quarterly Preferred Stock Liabilities came in at $366.0 million in Q4 2024.

Medline (MDLN) Preferred Stock Liabilities (2024) Analysis & Trends

Medline (MDLN) has 1 years of Preferred Stock Liabilities data on file, last reported at $366.0 million in Q4 2024.

  • On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $366.0 million in Q4 2024; TTM through Dec 2024 was $366.0 million, a N/A change from a year earlier, with the FY2024 full-year figure at $366.0 million, changed N/A from the prior year.
  • Preferred Stock Liabilities for Q4 2024 stood at $366.0 million.
  • Over the last five years, Preferred Stock Liabilities for MDLN reached as high as $366.0 million in Q4 2024 and fell as low as $366.0 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn -
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn -
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn -
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn -
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn -
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn -
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn -
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn -
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn -
10 Baxter International 11.17 Bn 9.12 Bn 891.00 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 366.00 Mn